Related Experiment Videos
Expression and regulation of the thrombopoietin receptor variants MPLP and MPLK in PBMC
I Rollinger-Holzinger1, U Griesser, V Pollak
1Centre Hospitalier de Luxembourg, Department of Hematology and Oncology, L-1210 Luxembourg, Austria.
Abstract:
The human c-mpl proto-oncogene encodes the receptor for thrombopoietin (TPO), which plays a central role in magakaryopoiesis and platelet production. Recent results showed that c-mpl mRNA expression is restricted to CD34(+) cells, megakaryocytes, and platelets. The authors analysed mRNA expression by reverse transcription and PCR (RT-PCR) of the transmembrane Mpl variants, MPLK and MPLP, in magakaryocytic cell lines, peripheral blood mononuclear cells (PBMC), lymphocytes, and monocytes. Transcription of both Mpl variants was detected in freshly isolated PBMC and the megakaryocytic cell line, DAMI, whereas none could be detected in the megakaryocytic cell line Meg-01. The cytokines TPO, interleukin 11 (IL-11), erythropoietin (EPO), and stem cell factor (SCF), which are known stimulators of megakaryopoiesis, but not interleukin3 (IL-3), increased MPLP mRNA detection in PBMC during 96 h of incubation. However, concomitantly the detection of MPLK transcripts decreased in these cells. MPLP was also detected in monocytes, B-lympocyte and T cell populations. In contrast, MPLK mRNA expression was low in monocytes, B and T cells, and no clear increase in transcription detection was observed during stimulation of these cells.
Insights
This study investigated thrombopoietin receptor (c-Mpl) variants in blood cells. MPLP mRNA expression increased with certain cytokines in peripheral blood mononuclear cells, while MPLK decreased.
Area of Science:
- Hematology
- Molecular Biology
- Cell Biology
Background:
- The c-Mpl proto-oncogene encodes the thrombopoietin (TPO) receptor, crucial for megakaryopoiesis and platelet production.
- Previous studies indicated c-Mpl mRNA expression is primarily in CD34(+) cells, megakaryocytes, and platelets.
Purpose of the Study:
- To analyze the mRNA expression of transmembrane Mpl variants, MPLK and MPLP.
- To investigate Mpl variant expression in various hematopoietic and immune cell populations.
- To determine the effect of cytokines on Mpl variant expression in peripheral blood mononuclear cells (PBMC).
Main Methods:
- Reverse transcription and PCR (RT-PCR) were employed to detect and analyze mRNA expression.
- Experiments involved megakaryocytic cell lines (DAMI, Meg-01), peripheral blood mononuclear cells (PBMC), lymphocytes, and monocytes.
- PBMCs were incubated with various cytokines (TPO, IL-11, EPO, SCF, IL-3) for 96 hours to assess their impact on Mpl variant transcription.
Main Results:
- Both MPLK and MPLP mRNA variants were detected in freshly isolated PBMCs and the DAMI cell line, but not in Meg-01.
- Cytokines TPO, IL-11, EPO, and SCF significantly increased MPLP mRNA detection in PBMCs, while MPLK mRNA detection decreased.
- MPLP mRNA was also found in monocytes, B cells, and T cells, with low MPLK mRNA expression in these populations, unaffected by cytokine stimulation.
Conclusions:
- The study reveals differential expression and regulation of MPLK and MPLP variants in hematopoietic and immune cells.
- Cytokine-mediated regulation of MPLP and MPLK mRNA in PBMCs suggests distinct roles in immune cell function and hematopoiesis.
- MPLP expression in monocytes and lymphocytes indicates potential roles beyond megakaryopoiesis.